Total Payments
$2,360
2024 Payments
$247.97
Companies
14
Transactions
30
Medicare Patients
2,280
Medicare Billing
$197,899
Payment Breakdown by Category
Food & Beverage$2,317 (98.2%)
Education$42.72 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,317 | 27 | 98.2% |
| Education | $42.72 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,030 | 12 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $249.80 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $247.97 | 2 | $0 (2024) |
| PFIZER INC. | $126.10 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $125.87 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $124.80 | 1 | $0 (2021) |
| Amgen Inc. | $119.24 | 1 | $0 (2019) |
| ABBVIE INC. | $117.37 | 1 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $116.82 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $26.83 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $247.97 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($125.00) |
| 2023 | $242.17 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($124.80) |
| 2022 | $11.71 | 1 | Lilly USA, LLC ($11.71) |
| 2021 | $124.80 | 1 | GlaxoSmithKline, LLC. ($124.80) |
| 2020 | $17.97 | 1 | Phadia US Inc. ($17.97) |
| 2019 | $364.26 | 4 | Novo Nordisk Inc ($130.95) |
| 2018 | $853.61 | 7 | Novo Nordisk Inc ($608.76) |
| 2017 | $497.15 | 12 | Novo Nordisk Inc ($290.17) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $122.97 | General |
| Category: Respiratory | ||||||
| 11/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $117.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: DIABETES | ||||||
| 06/16/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 06/22/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: RESPIRATORY | ||||||
| 03/04/2020 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.97 | General |
| Category: Allergy/Immunology | ||||||
| 07/24/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: Diabetes | ||||||
| 05/08/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $114.07 | General |
| Category: VACCINES | ||||||
| 03/20/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $119.24 | General |
| Category: Cardiology | ||||||
| 02/21/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 10/25/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $119.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 06/12/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 03/22/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $117.23 | General |
| Category: Diabetes | ||||||
| 03/06/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Diabetes | ||||||
| 02/27/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 01/24/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $121.53 | General |
| Category: Diabetes | ||||||
| 12/18/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 12/08/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $24.99 | General |
| 11/07/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Diabetes | ||||||
| 10/30/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Diabetes | ||||||
| 10/17/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Diabetes | ||||||
| 10/06/2017 | Janssen Scientific Affairs, LLC | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $116.82 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 10/03/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Education | In-kind items and services | $6.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 602 | 688 | $154,148 | $57,621 |
| 2022 | 12 | 562 | 619 | $130,838 | $49,691 |
| 2021 | 13 | 633 | 724 | $154,970 | $57,181 |
| 2020 | 11 | 483 | 543 | $97,077 | $33,406 |
Total Patients
2,280
Total Services
2,574
Medicare Billing
$197,899
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 120 | 120 | $48,000 | $16,441 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 142 | $38,056 | $13,211 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 88 | $16,016 | $5,947 | 37.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $8,295 | $5,629 | 67.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 16 | $11,744 | $3,759 | 32.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 51 | 51 | $6,681 | $3,665 | 54.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 14 | $7,574 | $2,428 | 32.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 61 | 61 | $3,111 | $1,983 | 63.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $5,040 | $1,966 | 39.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 18 | $2,538 | $800.10 | 31.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 57 | 74 | $1,702 | $687.02 | 40.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $1,071 | $650.00 | 60.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 48 | 48 | $4,320 | $454.82 | 10.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 111 | 111 | $44,400 | $15,711 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 102 | $27,336 | $10,092 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 104 | $18,928 | $6,849 | 36.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 54 | 54 | $6,960 | $3,695 | 53.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $4,345 | $3,070 | 70.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 12 | $8,808 | $2,898 | 32.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $8,400 | $2,560 | 30.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 58 | 58 | $2,958 | $1,856 | 62.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 16 | 17 | $1,855 | $1,197 | 64.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 53 | 70 | $1,610 | $670.14 | 41.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 18 | 18 | $918.00 | $580.30 | 63.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 47 | 48 | $4,320 | $513.60 | 11.9% |
About Dr. Leon Rapko, D.O
Dr. Leon Rapko, D.O is a Family Medicine healthcare provider based in Shelton, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619925377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leon Rapko, D.O has received a total of $2,360 in payments from pharmaceutical and medical device companies, with $247.97 received in 2024. These payments were reported across 30 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,317).
As a Medicare-enrolled provider, Rapko has provided services to 2,280 Medicare beneficiaries, totaling 2,574 services with total Medicare billing of $197,899. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Shelton, CT
- Active Since 05/05/2006
- Last Updated 07/06/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1619925377
Products in Payments
- Tresiba (Drug) $497.48
- Victoza (Drug) $290.17
- JARDIANCE (Drug) $249.80
- Ozempic (Drug) $242.23
- PREVNAR - 13 (Biological) $126.10
- BEVESPI AEROSPHERE (Drug) $125.00
- TRELEGY ELLIPTA (Drug) $124.80
- AIRSUPRA (Drug) $122.97
- XARELTO (Drug) $119.85
- Repatha (Biological) $119.24
- VRAYLAR (Drug) $117.37
- PREZCOBIX (Drug) $116.82
- ENTRESTO (Drug) $26.83
- TOUJEO (Drug) $20.29
- ImmunoCAP (Device) $17.97
- INVOKANA (Drug) $6.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Shelton
Dr. Samuel Streit, Do, DO
Family Medicine — Payments: $13,696
Family Medicine $13,696
Dr. Elliot Mathias, M.d, M.D
Family Medicine — Payments: $7,058
Family Medicine $7,058
Dr. Bharvi Balar, Md, MD
Family Medicine — Payments: $5,782
Family Medicine $5,782
Dr. Kenneth Ward, M.d, M.D
Family Medicine — Payments: $2,034
Family Medicine $2,034
Dr. Parnian Kiamanesh, M.d, M.D
Family Medicine — Payments: $1,983
Family Medicine $1,983
Andrea Buser, Pa-C, PA-C
Family Medicine — Payments: $1,760
Family Medicine $1,760